GCM
CDMO

Geneva Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Geneva Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,258,671
Closed -$21.3M – 128
2023
Q3 		$21.3M Sell
2,258,671
-61,299
-3% -$738K 0.45% 72
2023
Q2 		$32.4M Sell
2,319,970
-5,939
-0.3% -$101K 0.64% 59
2023
Q1 		$43.6M Buy
2,325,909
+489,128
+27% +$8.03M 0.89% 46
2022
Q4 		$25.3M Buy
1,836,781
+396,417
+28% +$6.07M 0.57% 66
2022
Q3 		$27.5M Buy
1,440,364
+74,014
+5% +$1.35M 0.64% 62
2022
Q2 		$20.9M Sell
1,366,350
-24,840
-2% -$367K 0.48% 82
2022
Q1 		$28.3M Buy
+1,391,190
New +$28.3M 0.55% 76

Other funds holding CDMO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return